Human maternofoetal distribution of pyrimethamine-sulphadoxine.
Trenque
T
T
Marx
C
C
Quereux
C
C
Leroux
B
B
Dupouy
D
D
Dorangeon
P H
PH
Choisy
H
H
Pinon
J M
JM
D000962:Antimalarials / Q000378:metabolism* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy / Q000517:prevention & control; D011739:Pyrimethamine / Q000378:metabolism* / Q000627:therapeutic use; D013413:Sulfadoxine / Q000378:metabolism* / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000188:drug therapy
D000962:Antimalarials; D013413:Sulfadoxine; D011739:Pyrimethamine